壹家壹品(08101.HK)首财季亏损扩大206%至756.1万港元
格隆汇8月8日丨壹家壹品(08101.HK)公布第一季业绩,截至2019年6月30日止3个月,公司实现收入3999.4万港元,同比基本持平;毛利1368.1万港元,同比增长15.2%;公司拥有人应占期内亏损756.1万港元,同比扩大206%;基本每股亏损0.26港仙;不派息。
公告表示,报告期内,集团营业额与去年的表现基本持平。另一方面,期内集团净亏损为约750万港元,较去年净亏损增加约205.9%。该纯利减少主要由于期内收购Green Step产生专业费用约170万港元以及与中国新厂房有关的经营租赁的财务费用约50万港元。此外,为收购Green Step而发行的承兑票据产生利息约160万港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.